ARHGAP26-AS1: A Potential Drug Target and Biomarker (G100874239)

Target Name: ARHGAP26-AS1

NCBI ID: G100874239

ARHGAP26-AS1

Other Name(s): ARHGAP26 antisense RNA 1

ARHGAP26-AS1: A Potential Drug Target and Biomarker

ARHGAP26-AS1 is a gene that encodes a protein located in the endoplasmic reticulum (ER) and has been identified as a potential drug target and biomarker. The ER is a complex organelle that plays a critical role in the regulation of protein synthesis, quality control, and degradation. Therefore, alterations in the ER can lead to a range of cellular and physiological changes. ARHGAP26-AS1 has been shown to be involved in the regulation of protein synthesis and stability, which suggests that it may be a promising drug target.

The Protein encoded by ARHGAP26-AS1

The ARHGAP26-AS1 gene encodes a protein with 26 amino acid residues. The protein has a calculated molecular weight of 34.1 kDa and a predicted localization in the ER. The ER is a complex organelle that is responsible for the synthesis, processing, and quality control of proteins. Therefore, it is expected that the ARHGAP26-AS1 protein plays a role in the ER function.

Expression of ARHGAP26-AS1

ARHGAP26-AS1 is expressed in various cell types, including human epithelial cells, brain cells, and cancer cells. The expression level of the protein varies depending on the cell type and the experimental conditions used for its production. In addition, the expression of ARHGAP26-AS1 has been shown to be regulated by various factors, including growth factors, oxygen availability, and cellular stress.

Drug Targeting Strategies

Drug targeting strategies have been proposed to target ARHGAP26-AS1 based on its unique expression patterns and the functions it is involved in. One approach is to use small molecules that can inhibit the activity of ARHGAP26-AS1 and disrupt its function in the ER. Another approach is to use antibodies that can specifically recognize and target ARHGAP26-AS1.

Biomarker Potential

ARHGAP26-AS1 has been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. The altered expression of ARHGAP26-AS1 has been observed in various diseases, which suggests that it may be a promising biomarker.

In conclusion, ARHGAP26-AS1 is a gene that encodes a protein located in the ER that is involved in the regulation of protein synthesis and stability. The protein has been shown to be expressed in various cell types and has been proposed as a potential drug target and biomarker. Further research is needed to fully understand the functions of ARHGAP26-AS1 and its potential as a drug target and biomarker.

Protein Name: ARHGAP26 Antisense RNA 1

The "ARHGAP26-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARHGAP26-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets